Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Depreciation & Amortization (CF) (2022 - 2025)

Historic Depreciation & Amortization (CF) for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to $16205.0.

  • Neuraxis' Depreciation & Amortization (CF) rose 7475.47% to $16205.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $42297.0, marking a year-over-year increase of 212.97%. This contributed to the annual value of $37831.0 for FY2024, which is 710.62% down from last year.
  • Neuraxis' Depreciation & Amortization (CF) amounted to $16205.0 in Q3 2025, which was up 7475.47% from $12885.0 recorded in Q2 2025.
  • Over the past 5 years, Neuraxis' Depreciation & Amortization (CF) peaked at $16205.0 during Q3 2025, and registered a low of $6356.0 during Q1 2025.
  • Over the past 4 years, Neuraxis' median Depreciation & Amortization (CF) value was $10220.5 (recorded in 2023), while the average stood at $10162.1.
  • Over the last 5 years, Neuraxis' Depreciation & Amortization (CF) had its largest YoY gain of 7475.47% in 2025, and its largest YoY loss of 4080.28% in 2025.
  • Over the past 4 years, Neuraxis' Depreciation & Amortization (CF) (Quarter) stood at $12086.0 in 2022, then fell by 13.66% to $10435.0 in 2023, then plummeted by 34.35% to $6851.0 in 2024, then surged by 136.53% to $16205.0 in 2025.
  • Its Depreciation & Amortization (CF) was $16205.0 in Q3 2025, compared to $12885.0 in Q2 2025 and $6356.0 in Q1 2025.